PlainRecalls
FDA Devices Moderate Class II Ongoing

cobas e801 Immunoassay Analyzer

Reported: August 17, 2022 Initiated: July 14, 2022 #Z-1515-2022

Product Description

cobas e801 Immunoassay Analyzer

Reason for Recall

Software issue resulting in signals and sample test results of Pre-Wash tests being impacted. The following assays are considered impacted by the issue: Anti-HAV2, Anti-HBc IgM, IGF-1, Myogloin, Rubella IgG, and Toxo IgG.

Details

Units Affected
965 units
Distribution
US Nationwide distribution including in the states of AK, AL, AR, AZ, CA, CO, CT, FL, GA, HI, IA, ID, IL, IN, KS, KY, LA, MA, MD, ME, MI, MN, MO, MS, MT, NC, NH, NJ, NM, NV, NY, OH, OK, OR, PA, RI, SC, TN, TX, UT, VA, WA, WI, WV, WY, DC & PR.
Location
Indianapolis, IN

Frequently Asked Questions

What product was recalled?
cobas e801 Immunoassay Analyzer. Recalled by Roche Diagnostics Operations, Inc.. Units affected: 965 units.
Why was this product recalled?
Software issue resulting in signals and sample test results of Pre-Wash tests being impacted. The following assays are considered impacted by the issue: Anti-HAV2, Anti-HBc IgM, IGF-1, Myogloin, Rubella IgG, and Toxo IgG.
Which agency issued this recall?
This recall was issued by the FDA Devices on August 17, 2022. Severity: Moderate. Recall number: Z-1515-2022.